MedTrace Logo

Controlling Oral Malodor by ClōSYS® Oral Rinse

NCT03160560 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2021-01-07

Study results available
· View outcomes & findings →

Summary

The purpose of this Study is to assess the efficacy of two ClōSYS Oral Rinse products in human subjects in controlling oral malodor in partial fulfillment of the requirements for American Dental Association's (ADA) requirement for obtaining ADA Seal for malodor.

Conditions

  • Oral Malodor

Interventions

DRUG

ClōSYS® Unflavored Rinse

Subjects in Test group will receive ClōSYS® Unflavored Rinse.

DRUG

ClōSYS® Flavored Rinse

Subjects in Test group will receive ClōSYS® Flavored Rinse.

OTHER

Placebo

Subjects in Placebo group will receive Placebo Rinse.

Sponsors & Collaborators

  • Loma Linda University

    collaborator OTHER

  • Rowpar Pharmaceuticals, Inc.

    lead INDUSTRY

Principal Investigators

  • Yiming Li, DDS MSD PhD · Center for Dental Research, Loma Linda University School of Dentistry

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2016-11-30
Completion
2016-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03160560 on ClinicalTrials.gov